Uncertainty around the event and suspected tax changes in the upcoming budget has left many investors in the dark.

GSK settles 93% of Zantac lawsuits with a $2.2 billion payout, easing investor concerns. However, doubts over its future ...

Nodenza Venture Partners launchedFocus on international early-stage and pre-commercial biotech & medtech opportunitiesNew York, October 16, ...

Stellantis CEO Carlos Tavares on Monday declined to rule out job cuts and said keeping up with Chinese competition and ...

British Prime Minister Keir Starmer kicked off an international business investment summit aimed at pulling in billions of ...

RSV vaccine sales from GSK and Pfizer have dropped significantly following revised CDC guidelines, narrowing the eligible age ...

John Maraganore, the former CEO of Alnylam Pharmaceuticals, launched City Therapeutics, a new startup with $135 million from ...

Speculation is mounting GlaxoSmithKline's CEO Emma Walmsley may pay the price for the company’s lacklustre performance, after the dreaded activist investor Elliott Management built a stake in ...

Dr. Baldoni’s career includes 29 years in R&D at GSK, where he served as Senior Vice President of ... "We are pleased to welcome Dr. Baldoni to our Scientific Advisory Board," said Vin Singh, CEO of ...

GlaxoSmithKline (GSK) appears to be focusing more on finding a new CEO than any large M&A deals after last year's $20 billion asset swap with Novartis, according to a briefing following strong Q1 ...

EasyJet has hired Jan De Raeymaeker as its finance chief from European rail freight operator Lineas, replacing Kenton Jarvis ...

Starmer promised of the Labour government that “Our door is open,” when the corporations are in fact already inside dictating ...